Dicerna Pharmaceuticals Inc

Pharmaceutical company · Lexington, Massachusetts, United States

Dicerna Pharmaceuticals Inc is a pharmaceutical company headquartered in Lexington, Massachusetts, United States. Its earliest recorded incorporation is in 2006. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $7.2 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $60 million sold in a notice filed in 2013.

www.dicerna.comProfile compiled from public records. Is this your company? Request a correction or update

Dicerna Pharmaceuticals at a glance

Typepharmaceutical company
HeadquartersLexington, Massachusetts, United States
Earliest incorporation on record2006
SEC industryPharmaceutical Preparations
Employees (per SBIR records)60
SEC CIK1399529

What does Dicerna Pharmaceuticals do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $7.2 million in total (2015 to 2020). NIH funding came from the National Institute on Alcohol Abuse and Alcoholism, National Cancer Institute.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $60 million sold (2013).

Frequently asked questions about Dicerna Pharmaceuticals

Where is Dicerna Pharmaceuticals headquartered?

Dicerna Pharmaceuticals Inc is headquartered in Lexington, Massachusetts, United States.

What does Dicerna Pharmaceuticals do?

Dicerna Pharmaceuticals Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

When was Dicerna Pharmaceuticals founded?

The earliest incorporation on record for Dicerna Pharmaceuticals Inc is in 2006, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.